placeholder image
K. Kubiak All authors
About
Publications While At 开云体育
selected publications
Journal Article
  • Durvalumab as third-line or later treatment for advanced non-small-cell lung cancer (ATLANTIC): an open-label, single-arm, phase 2 study. 
    Lancet Oncology. 2018
  • Overall survival with durvalumab after chemoradiotherapy in stage III NSCLC. 
    New England Journal of Medicine. 2018
  • Durvalumab after chemoradiotherapy in stage III non-small-cell lung cancer. 
    New England Journal of Medicine. 2017
  • Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial. 
    Lancet Oncology. 2017
    • Contact
    full name
  • K. Kubiak
    • Quick Info
    Publications
    Publications in the past 10 years based solely on publications while at 开云体育. Publications in prior years appear in grey.
    Collaboration